🔎 Trials Near Me

Gara Jalqabaatti › Kansara Metastatikii › Alabama

Qorannoo klinikaalii Kansara Metastatikii Alabama keessatti

Qorannoo 13 Kansara Metastatikii f Alabama keessatti hirmaatuu jiru.

Magaalota Alabama keessatti

Takkalaa qorannoo (Ingiliffa)

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Clearview Cancer Institute, Huntsville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • University of Alabama at Birmingham Cancer Center, Birmingham
  • University of South Alabama Mitchell Cancer Institute, Mobile
Namoota walitti qabaa jiraSadarkaa 2
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

PRE-ISPY Phase I/II Oncology Platform Program

  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05868226

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • The University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06943755

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • The Kirklin Clinic of UAB Hospital, Birmingham
  • The University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06989437

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  • Clinical Study Site, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Clearview Cancer Institute, Huntsville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

  • University of Alabama at Birmingham Cancer Center, Birmingham
Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT04657068

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  • Central Alabama Research, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT06216301

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Birmingham
  • Massive Bio SYNERGY-AI site, Mobile
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.